Dan Nandan is the CEO of Staffingly, Inc. With 25+ years in IT consulting and a decade leading healthcare BPO operations across India, Latin America, and Pakistan, his team now serves 800+ U.S. healthcare providers across medical, dental, pharmacy, and post-acute care verticals.
2026 Compliance Verified: HIPAA, SOC 2 Type II, ISO 27001, HITRUST-aligned workflows.
Featured in Computerworld →
State of Illinois. Registered Professional Nurse
Bincy Shiiju Kuriakose is a U.S.-licensed Registered Nurse (MSN, RN), NCLEX-RN certified, with expertise in hospital nursing, telehealth, and nursing education. She reviews every publication for medical accuracy, YMYL compliance, and evidence-based clinical context.
What Is a Clinical Pharmacist Medication Review?
A structured workflow where a pharmacist evaluates every medication a hospitalized patient is taking, has been prescribed, or should be taking. It happens at admission, transfer, and discharge. Unlike a simple medication list check, the review evaluates therapeutic appropriateness, dosing accuracy, drug interactions, and whether every medication on the home list should continue during hospitalization.
Why Hospital Medication Review Matters
More than 40% of medication errors in hospitals are attributed to inadequate reconciliation at care transitions, and about 20% of those discrepancies result in patient harm (AHRQ PSNet). Each adverse drug event costs an average of $3,420 and extends the hospital stay by 3.15 days. Nationally, ADEs from medication alert overrides alone cost $871 million to $1.8 billion per year. For hospitals in New York, New Jersey, and California, state-specific regulations add additional documentation and reporting requirements on top of Joint Commission and CMS mandates.
The core problem is time. A clinical pharmacist reviewing medications for a patient on 12-15 drugs from three prescribers needs 30-45 minutes just to collect the medication history. Multiply that by 20-30 patients on a service line, and the pharmacist’s entire shift can be consumed by administrative tasks that do not require a PharmD. The clinical judgment, drug interaction evaluation, and dose adjustment recommendations that justify a pharmacist’s training and salary get pushed aside by phone calls to retail pharmacies and data entry into reconciliation templates. This guide covers the clinical pharmacist-led medication review process, the regulatory requirements that mandate it, the specific errors pharmacists catch, the administrative burden that consumes most of the pharmacist’s time, and the portions of the workflow that can be outsourced to free pharmacists for the clinical work only they can do.
Why Clinical Pharmacist-Led Medication Review Matters
Unintentional discrepancies at admission cause an adverse drug event in one of every five cases (AHRQ PSNet). Each ADE costs $3,420 and extends stays by 3.15 days. Nationally, 196,600 ADEs from medication alert overrides alone cost $871 million to $1.8 billion/year.
Pharmacist-led reconciliation improved medication accuracy from 45.8% to 95% per patient in one multicenter study (PMC 2023). 89% of studies documented reduced 30-day readmissions after pharmacy-led transitions programs.
The 5-Step Medication Review Process (WHO/Joint Commission Standard)
Step 1: Collect the Best Possible Medication History (BPMH). Compile a complete medication list from the patient interview, caregiver input, retail pharmacy records, EHR data, and PCP records. The BPMH includes all active prescriptions, OTC medications, supplements, herbal products, and recently discontinued medications. This step is the most time-consuming, often taking 30-45 minutes for complex patients, and it is also the step most suitable for administrative support because it involves data collection rather than clinical judgment.
Step 2: List All Current Hospital Orders. Document every new medication ordered during the hospitalization, every medication continued from the home list, and every medication that has been held or discontinued since admission.
Step 3: Compare the Two Lists. Flag every difference between the BPMH and the current orders: missing home medications that should have been continued, dose changes without documented rationale, duplicate therapies from different prescribers, new medications with potential interactions, and therapeutic substitutions that were made without provider notification.
Step 4: Resolve Discrepancies. The pharmacist works directly with the prescribing physician to restart omitted home medications, adjust doses based on the patient’s current clinical status and lab values, discontinue duplicate therapies, and document the rationale for every change. This step requires the pharmacist’s clinical expertise and cannot be delegated to administrative support.
Step 5: Communicate the Final Reconciled List. Document the final medication list in the EHR with clear annotations showing what was added, removed, or changed and why. At discharge, provide the patient with a written medication list in plain language that explains each medication’s purpose, dose, and schedule.
This five-step process repeats at every care transition: admission, unit transfer, and discharge. Each transition is a risk point where medications can be unintentionally omitted, duplicated, or continued at incorrect doses.
Save 40-70% with dedicated Pharmacy specialists
Book a 15-minute call. We will map your current pharmacy services workflow, denial rates, and staff hours against what a dedicated team typically delivers in the first 30 days.
Common Medication Errors Caught During Hospital Reviews
Wrong dose for renal impairment is one of the most frequent findings. A patient with a GFR of 30 admitted on a standard dose of a renally-cleared medication can develop toxicity within days. The pharmacist catches this by cross-referencing lab values with dosing guidelines. Duplicate therapy is another common issue, such as two anticoagulants prescribed by different providers who are unaware of each other’s orders. Drug-drug interactions like amiodarone plus a statin can cause rhabdomyolysis if not caught and managed. Omitted home medications happen when a patient’s admission orders do not include a medication they were taking at home, leading to withdrawal symptoms or disease flare. Therapeutic substitution without documentation occurs when a formulary-equivalent drug is substituted but the prescribing provider is not informed, creating confusion at discharge.
Each of these errors is preventable with structured pharmacist review. The pharmacist’s clinical expertise is what catches them. But the pharmacist cannot review clinical issues if they are spending their time calling pharmacies to collect medication lists, typing up reconciliation documentation, and tracking completion metrics for Joint Commission surveys.
Joint Commission and CMS Requirements for 2026
Joint Commission NPSG 03.06.01 requires maintaining and communicating accurate medication information. The requirement covers admission, transfer, and discharge with five elements of performance.
CMS Inpatient Quality Reporting tracks medication reconciliation as a quality measure affecting star ratings and value-based purchasing.
Leapfrog Group 2026 assesses adherence to endorsed medication reconciliation protocols.
Despite requirements, only 78% of hospitals report pharmacy involvement in reconciliation, and fewer than 5% use pharmacy-provided admission histories (AHRQ PSNet). This gap between regulatory expectation and operational reality exposes hospitals to survey findings and creates preventable patient harm.
The Administrative Burden Behind Every Medication Review
Collecting the BPMH for a single patient on 12-15 medications from three prescribers takes 30-45 minutes. That time is spent calling retail pharmacies, cross-referencing EHR records from multiple systems, interviewing the patient or caregiver about medications that may not appear in any electronic record, and typing the results into a reconciliation template. After collection, every discrepancy must be logged, every intervention documented with clinical rationale, and every resolution communicated to the prescribing team and recorded in the EHR.
Pharmacists consistently report that administrative tasks consume 60% or more of their shift time. For a pharmacist covering a 25-patient service line, that translates to 12-18 hours per day of medication history collection and documentation, leaving only a fraction of the shift available for the clinical review work that actually requires their PharmD training.
The fix is structural: separate the administrative layer from clinical decision-making. History collection, documentation, follow-up tracking, formulary lookups, and completion rate monitoring can all be performed by trained administrative professionals. The pharmacist then receives pre-populated reconciliation templates and focuses exclusively on drug interaction evaluation, dose adjustment recommendations, therapeutic substitution decisions, and prescriber communication. This model does not reduce pharmacist involvement in patient care. It increases it by removing the tasks that do not require clinical judgment.
What Parts of Medication Review Can Be Outsourced?
Outsourceable: Medication history collection, discrepancy documentation, post-discharge follow-up tracking, completion rate tracking for Joint Commission/CMS, formulary and coverage data pulls, reconciliation summaries, post-discharge follow-up calls.
Stays with the US-licensed pharmacist: Drug interaction evaluation, dose adjustment recommendations, therapeutic substitution decisions, prescriber communication, patient counseling.
Staffingly provides trained virtual professionals at $399/week (volume discounts to $299/week) vs. $55-75/hour for US-based pharmacy technicians. 70% cost reduction on support tasks.
How Staffingly Supports Hospital Medication Review Teams
48-72 hour go-live. 50+ EHR platforms (Epic, Cerner, MEDITECH, Allscripts, eCW). SOC 2 Type II, HITRUST, ISO 27001, HIPAA compliant. 800+ providers.
Virtual professionals pull medication histories, pre-populate reconciliation templates, flag discrepancies, document interventions, track completion metrics, and handle post-discharge calls. The pharmacist starts their shift with histories collected and templates populated.
State-by-State Requirements (NY, NJ, CA)
New York. Education Law Section 6801 defines pharmacist scope. NYS DOH requires documented reconciliation at licensed acute care facilities. NY Medicaid MCOs have distinct formularies affecting medication continuation.
New Jersey. N.J.A.C. 13:39 governs pharmacy practice. Patient Safety Act mandates reporting medication-related adverse events. Collaborative practice agreements expand pharmacist roles.
California. B&PC Section 4052 grants clinical pharmacists authority under collaborative agreements. Medi-Cal requires reconciliation at transitions. CDPH licensing requires documented processes.
AI and Technology in Medication Review (2026 Update)
AI tools are entering medication reconciliation workflows in 2026. Approximately 75% of hospitals are evaluating or piloting AI-assisted clinical decision support tools (HIMSS 2024). AI can scan medication lists for interactions, flag dosing concerns based on lab values, and pre-populate reconciliation templates from EHR data. However, 65% of pharmacists report that AI tools still require significant human oversight, particularly for complex polypharmacy patients and off-label medication use.
Natural language processing tools can extract medication information from unstructured clinical notes, discharge summaries, and external pharmacy records, reducing the time spent on manual data collection. Approximately 45% of large health systems have implemented some form of automated medication history collection (HIMSS 2024). The technology works best when the data sources are clean and standardized. When records come from multiple systems with different formatting conventions, human review remains essential.
The practical takeaway: AI handles the data collection layer effectively but cannot replace the pharmacist’s clinical judgment. The combination of AI-assisted data gathering with human clinical review is the model hospitals are moving toward in 2026. For outsourcing, this means the administrative support layer (collecting histories, populating templates, tracking metrics) pairs well with AI tools while the clinical review stays with the licensed pharmacist.
Warning Signs Your Process Needs Help
Five indicators that your medication review process needs structural intervention.
Pharmacists spending 50% or more of their shift on administrative tasks instead of clinical review. If your pharmacists are spending the majority of their time on phone calls, data entry, and documentation rather than evaluating drug interactions and making clinical recommendations, the administrative layer is not adequately staffed.
Completion rates below 85% at discharge. Joint Commission and CMS expect reconciliation at every care transition. When completion rates drop below 85%, it typically means the pharmacist team is overwhelmed and cutting corners on documentation or skipping transitions entirely.
Above-average readmission rates for medication-related causes. If patients are returning to the hospital within 30 days due to medication errors, missed medications, or adverse drug events, the reconciliation process at discharge is not catching problems before the patient leaves.
Joint Commission flags on reconciliation during surveys or mock surveys. Any finding related to NPSG 03.06.01 signals a process gap that needs immediate attention.
Unfilled pharmacy technician positions for 90 or more days. When you cannot hire support staff to handle the administrative workload, the pharmacist absorbs it. This creates a downward spiral where clinical quality declines as administrative burden increases.
Conclusion
Clinical decisions belong to licensed pharmacists. Administrative work (history collection, documentation, follow-up tracking) does not require a pharmacist salary. When hospitals separate these two layers, pharmacists spend their time on drug interaction evaluation, dose adjustments, and prescriber communication instead of calling retail pharmacies and typing up reconciliation summaries. The result is better patient safety, higher completion rates, and more efficient use of a scarce clinical resource. Hospitals that have implemented this separation consistently report that pharmacist job satisfaction increases alongside patient safety metrics, because pharmacists can finally practice at the top of their license rather than functioning as expensive data entry clerks.
Staffingly provides trained virtual professionals at $399/week (volume discounts to $299/week) who handle the administrative layer. 800+ providers. 48-72 hour go-live. SOC 2 Type II, HITRUST, HIPAA compliant. The pharmacist starts their shift with histories already collected and templates already populated.
FAQ
Q1: What is a medication review by a clinical pharmacist? A structured process where a pharmacist evaluates all medications, compares them to orders, identifies discrepancies, and resolves errors. Happens at admission, transfer, and discharge per Joint Commission NPSG 03.06.01.
Q2: Why is medication reconciliation required? Joint Commission requires it for accreditation. CMS tracks it for quality reporting and star ratings. Leapfrog includes it in 2026 ratings. Non-compliance affects accreditation and reimbursement.
Q3: How many errors come from poor reconciliation? Over 40% of hospital medication errors are attributed to inadequate reconciliation. 20% of discrepancies result in harm (AHRQ). ADEs cost $3,420 per event with 3.15 extra days.
Q4: What parts can be outsourced? Administrative tasks: history collection, documentation, follow-up tracking, formulary lookups, and post-discharge calls. Clinical decisions stay with the US-licensed pharmacist. Outsourcing removes 60%+ of the time burden.
Q5: How much does outsourcing cost? $399/week (volume discounts to $299/week) vs. $55-75/hour for US-based pharmacy technicians. Up to 70% savings on support tasks. SOC 2 Type II, HITRUST, HIPAA compliant.
Q6: Does Staffingly work with hospital EHRs? Yes. 50+ platforms including Epic, Cerner, MEDITECH, Allscripts, and eCW. Secure VPN with role-based access and audit logging.
Q7: How quickly can staff be deployed? 48-72 hours from signed agreement. Staffingly maintains 500+ trained virtual professionals who are credentialed and system-ready. The onboarding process includes EHR access configuration, workflow documentation review, reconciliation template orientation, and a supervised first-day session where the assigned professional demonstrates competency on your specific system before working independently. For hospitals with complex medication reconciliation workflows involving multiple EHR modules, the orientation period may extend to 5 business days to ensure full proficiency before unsupervised work begins.
Ready to Free Your Pharmacists for Clinical Review?
Staffingly provides trained virtual professionals who handle the administrative layer of medication review: history collection, discrepancy documentation, follow-up tracking, and post-discharge calls. Your US-licensed pharmacists keep the clinical decisions and start each shift with histories collected and reconciliation templates populated. SOC 2 Type II, HITRUST, and ISO 27001 certified. HIPAA compliant.
- Start a 15-Day Risk-Free Pilot and see results before you commit.
- Call us: (800) 489-5877
Frequently Asked Questions
See how Staffingly supports the administrative layer of medication review: medication reconciliation support, post-discharge follow-up, and transitional care support.
